| Accession |
PRJCA011056 |
| Title |
Pharmacokinetic effects of apatinib mesylate on CYP2C8 substrate repaglinide and CYP2B6 substrate bupropion in patients with advanced solid tumors with single arm, open and fixed sequences |
| Relevance |
Medical |
| Data types |
clinical,image,Metabolic,Biomarker,Genetic data
|
| Organisms |
Homo sapiens
|
| Description |
Pharmacokinetic effects of apatinib on CYP2C8 substrate repaglinide, CYP2B6 substrate bupropion and metabolite hydroxylbupropion |
| Sample scope |
Multiisolate |
| Release date |
2022-08-08 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Jiangsu Hengrui Pharmaceutical Co., LTD
|
|
NA
|
|
|
|
| Submitter |
wanqiu
liang (wanqiu.liang@hengrui.com)
|
| Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
| Submission date |
2022-08-08 |
